脑部放疗,上午比下午敏感许多!) T6 e. A) s/ k3 V; z+ Q6 x1 @' f
5 Z# c- z- E2 i/ I- i J( f3 s7 |
+ T1 V) d* N' \! x4 A: XCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.1 Q+ x5 O1 V1 Z. X; S7 T; v' e
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
5 M* A1 O T2 b: rRahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.4 p! g" d1 [/ h. S
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
7 G2 j$ N2 ~! J* B3 f9 E- g {6 ?6 B4 J$ T7 s* D8 q
Abstract0 k# a, y5 Y7 `6 X. s6 i) ?
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.0 j) V+ C# h0 a# B! L7 P7 E2 g
( [5 O6 u ^0 ^. M! M. W- wMETHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
& j" P v! N$ w* B* a& y
0 G# `5 j) o0 B CRESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026). Q/ H) ^2 I# `8 B3 Z n% I
/ _: t A4 z- n9 A+ RCONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
5 B1 ^+ ~3 M: |" {" J% M6 S, L
! a- E' s" ? u |